 | This article needs to be updated. (May 2017) |
| Company type | Subsidiary |
|---|---|
| Industry | Medical devices |
| Founded | California, U.S.(March 1, 1976) |
| Headquarters | |
Area served | Global |
Key people | D. Keith Grossman President and CEO
Daniel M. Mulvena[1] |
| Products | mechanical circulatory support devices |
Number of employees | 1,048 (2014)[2] |
| Parent | Abbott Laboratories |
| Website | Thoratec.com |
Thoratec Corporation is a United States–based company that develops, manufactures, and markets proprietary medical devices used for mechanical circulatory support for the treatment of heart-failure patients worldwide. It is a global leader in mechanical circulatory support devices, particularly in ventricular assist devices (VADs).[3][4]
For chronic circulatory support for late-stage heart-failure patients, Thoratec's primary product lines are its ventricular assist devices: the HeartMate 3 Left Ventricular Assist System (HeartMate 3), and the Thoratec Paracorporeal Ventricular Assist Device (PVAD). For acute circulatory support, the company's product lines are the CentriMag Acute Circulatory System (CentriMag); and for pediatric patients the PediMag Acute Circulatory System, known as PediVAS outside the U.S.
Incorporated in 1976, Thoratec is headquartered in Pleasanton, California. In 2015 the company was acquired by St. Jude Medical, a global medical-device company headquartered in Saint Paul, Minnesota. In January 2017, St. Jude was acquired by Abbott Laboratories.
- ^ "E10vq".
- ^ 2014 Annual Report. Thoratec Corporation. Retrieved October 10, 2015.
- ^ "Thoratec, A Bio Stock With Good Potential And Products". Seeking Alpha. May. 23, 2013.
- ^ "Research and Markets: Global Ventricular Assist Devices (VAD) Market 2015-2019 with Abiomed, HeartWare International & Thoratec Dominating". Business Wire. February 18, 2015.